机译:结合RNAi和铂类抗癌药时可最大化协同活性
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States;
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States;
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States;
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States,Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States;
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States,Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States;
Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, United States;
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States;
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States;
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States;
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States;
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States;
State Key Laboratory of Polymer Physics and Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, People's Republic of China;
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States;
Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, United States;
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States,Dana-Farber Cancer Institute, Boston, Massachusetts 02115, United States;
机译:生育三烯酚与化学治疗剂或饮食成分联合的协同抗癌作用:综述
机译:水生大黄菌蛋白聚糖与抗癌剂的混合物对人结肠癌细胞HT29的协同抗癌活性
机译:共同递送纳米疗法的协同抗癌活性和结肠癌中的siRNA
机译:通过计算方法研究铂基抗癌复合物活动的见解
机译:新的 铂类 抗癌药物 的 发展目标定位 卵巢 癌干细胞
机译:生育三烯酚与化学治疗剂或膳食成分联合的协同抗癌作用:综述
机译:在结合RNAI和基于铂金的抗癌代理时最大化协同活动